Number 5: Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat inflammatory diseases, while Celltrion secured Korean approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback